TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Merck Life Science Oy
Closing information (x1000 NOK)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
74,989
|
74,140
|
49,558 |
| Financial expenses |
9
|
10
|
36 |
| Earnings before taxes |
2,272
|
1,740
|
2,814 |
| Total assets |
18,900
|
17,808
|
15,599 |
| Current assets |
245
|
239
|
561 |
| Current liabilities |
6,479
|
6,644
|
6,334 |
| Equity capital |
12,412
|
11,155
|
9,257 |
| - share capital |
1,272
|
1,338
|
1,267 |
| Employees (average) | 8 | 7 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
65.7%
|
62.6%
|
59.3% |
| Turnover per employee | 9,374 | 7,080 | |
| Profit as a percentage of turnover |
3.0%
|
2.3%
|
5.7% |
| Return on assets (ROA) |
12.1%
|
9.8%
|
18.3% |
| Current ratio |
3.8%
|
3.6%
|
8.9% |
| Return on equity (ROE) |
18.3%
|
15.6%
|
30.4% |
| Change turnover |
4,516
|
21,785
|
2,389 |
| Change turnover % |
6%
|
42%
|
5% |
| Chg. No. of employees | -1 | ||
| Chg. No. of employees % | -13% |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.